Table 3.
Association of clinical sign & symptoms with HSV-2 seroprevalence among pregnant women of Northeast India (n = 1640).
| Clinical sign & symptoms |
Response/findings (n) | HSV-2 Sero prevalence n (%) |
Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI |
P value |
AOR | 95% CI |
P value |
|||
| Cervicitis | No (1447) | 107 (7.4) | Ref | -- | -- | Ref | -- | -- |
| Yes (193) | 35 (18.1) | 2.80 | 1.8-4.2 | < 0.001 | 2.14 | 1.36-3.38 | 0.001 | |
| Genital ulcer | No (1621) | 135 (8.3) | Ref | -- | -- | Ref | -- | -- |
| Yes (19) | 07 (36.8) | 6.42 | 2.5-16.6 | < 0.001 | 4.11 | 1.38-12.21 | 0.011 | |
| Pelvic pain | No (1423) | 105 (7.4) | Ref | -- | -- | Ref | -- | -- |
| Yes (217) | 37 (17.1) | 2.58 | 1.72-3.87 | < 0.001 | 2.20 | 1.40-3.45 | 0.001 | |
| Excess vaginal discharge | No (1003) Yes (637) |
66 (6.6) 76 (11.9) |
Ref 1.92 |
-- 1.36-2.72 |
-- < 0.001 |
Ref 1.46 |
-- 1.00-2.15 |
-- 0.053 |
AOR: Adjusted Odds Ratio; 95% CI: 95% confidence interval